1. Home
  2. CACC vs BLCO Comparison

CACC vs BLCO Comparison

Compare CACC & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CACC
  • BLCO
  • Stock Information
  • Founded
  • CACC 1972
  • BLCO 1853
  • Country
  • CACC United States
  • BLCO Canada
  • Employees
  • CACC N/A
  • BLCO N/A
  • Industry
  • CACC Finance: Consumer Services
  • BLCO Ophthalmic Goods
  • Sector
  • CACC Finance
  • BLCO Health Care
  • Exchange
  • CACC Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • CACC 6.0B
  • BLCO 6.3B
  • IPO Year
  • CACC 1992
  • BLCO 2022
  • Fundamental
  • Price
  • CACC $495.56
  • BLCO $15.77
  • Analyst Decision
  • CACC Sell
  • BLCO Buy
  • Analyst Count
  • CACC 2
  • BLCO 12
  • Target Price
  • CACC $440.00
  • BLCO $19.82
  • AVG Volume (30 Days)
  • CACC 62.0K
  • BLCO 734.7K
  • Earning Date
  • CACC 01-30-2025
  • BLCO 02-19-2025
  • Dividend Yield
  • CACC N/A
  • BLCO N/A
  • EPS Growth
  • CACC N/A
  • BLCO N/A
  • EPS
  • CACC 19.88
  • BLCO N/A
  • Revenue
  • CACC $928,200,000.00
  • BLCO $4,791,000,000.00
  • Revenue This Year
  • CACC N/A
  • BLCO $17.29
  • Revenue Next Year
  • CACC $5.28
  • BLCO $5.47
  • P/E Ratio
  • CACC $25.09
  • BLCO N/A
  • Revenue Growth
  • CACC 3.23
  • BLCO 15.56
  • 52 Week Low
  • CACC $409.22
  • BLCO $13.16
  • 52 Week High
  • CACC $614.96
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • CACC 44.50
  • BLCO 32.89
  • Support Level
  • CACC $499.05
  • BLCO $15.62
  • Resistance Level
  • CACC $528.49
  • BLCO $16.60
  • Average True Range (ATR)
  • CACC 12.26
  • BLCO 0.46
  • MACD
  • CACC -2.43
  • BLCO -0.05
  • Stochastic Oscillator
  • CACC 7.81
  • BLCO 7.01

About CACC Credit Acceptance Corporation

Credit Acceptance Corp is a consumer finance company that specializes in automobile loans. These loans are offered through a U.S. nationwide network of automobile dealers that benefit from sales of vehicles to consumers who could otherwise not obtain financing. The company also benefits from repeat and referral sales, and from sales to customers responding to advertisements for financing, but qualify for traditional financing. The company derives its revenue from finance charges, premiums earned on the reinsurance of vehicle service contracts, and other fees. Of these, financing charges, including servicing fees, are by far a source of revenue.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: